SERPINA3 in Diabetic Retinopathy: A Pilot Study Assessing the Impact of Prior COVID-19 Infection on Patients
Overall, SERPINA3 had poor sensitivity and specificity for identifying DR patients, and COVID-19 infection history significantly increased variance in SERPINA3 levels. Further investigation into the potential of SERPINA3 as DR biomarker should be sufficiently powered to account for the potentially confounding effects of COVID-19 infection.
Authors
- Ashok Sharma (ORCID: https://orcid.org/0000-0001-9597-4374)
- Vikas Kumar (ORCID: https://orcid.org/0000-0002-2975-0273)
- Shruti Sharma (ORCID: https://orcid.org/0000-0001-8200-108X)
- Rebekah Robinson (ORCID: https://orcid.org/0000-0001-9234-6209)
- Eunheh Koh
- Arthur S. Miller
Institutions
- Augusta University (US)
- Discovery Institute (US)
Publication Details
- Journal
- Current Eye Research
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1080/02713683.2025.2494795
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00